MedTrace Logo

Reducing Hazardous Alcohol Use & Human Immunodeficiency Virus (HIV) Viral Load

NCT02720237 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 441

Last updated 2018-10-12

No results posted yet for this study

Summary

The purpose of this study is to compare the effectiveness of two interventions \[a Brief Intervention (BI) and a Motivational Enhancement Therapy+Cognitive Behavioral Therapy (MET+CBT) Intervention\], against each other and with an assessment-only control, in improving both alcohol- and HIV-related outcomes, among hazardous and heavy drinking HIV-infected antiretroviral therapy (ART) clinic clients in Thai Nguyen, Vietnam.

Conditions

  • Alcohol Drinking
  • HIV

Interventions

BEHAVIORAL

Brief Intervention

In-person individual sessions (occurring one month apart) and booster phone sessions (occurring 2-3 weeks after each in-person session), delivered by a trained counselor.

BEHAVIORAL

Motivational Enhancement Therapy (MET) Intervention

In-person individual sessions (one session per week) and optional group sessions, delivered by a trained counselor.

BEHAVIORAL

Cognitive Behavioral Therapy (CBT) Intervention

In-person individual sessions (one session per week) and optional group sessions, delivered by a trained counselor.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Thai Nguyen Center for Preventive Medicine

    collaborator UNKNOWN

  • Johns Hopkins University

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Vivian F Go, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-06-19
Completion
2018-06-19

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02720237 on ClinicalTrials.gov